MUTYH Gene Polymorphisms as Risk Factors for Rheumatoid Arthritis

Yung-Jen Kung1, Kun Shi Tsai2, Chung-Ming Huang3

  • 1Department of Veterinary Medicine, National Chung Hsing University, Taichung 40227, Taiwan.

Abstract

Insights

Genetic variations in the MUTYH gene, specifically rs3219463 and rs3219476, are linked to rheumatoid arthritis (RA) susceptibility in a Taiwanese population, suggesting MUTYH

Area of Science:

  • Genetics
  • Immunology
  • Molecular Biology

Background:

  • MUTYH glycosylase is crucial for DNA repair pathways.
  • Autoimmune diseases, such as rheumatoid arthritis (RA), are complex conditions with potential genetic underpinnings.
  • The role of DNA repair gene polymorphisms in RA pathogenesis requires further investigation.

Purpose of the Study:

  • To investigate the association between specific MUTYH gene polymorphisms and the risk of developing RA.
  • To analyze the correlation between MUTYH gene variations and RA susceptibility in a Taiwanese Chinese population.

Main Methods:

  • Case-control study involving 192 RA patients and 192 healthy controls from Taiwan.
  • Genotyping of four MUTYH polymorphisms (rs3219463, rs3219476, rs3219489, rs3219493) using standard methods.
  • Haplotype analysis performed using Bayesian methods, with genotype and allele frequencies compared via chi-square tests.

Main Results:

  • Significant differences in genotype and allele frequencies were observed for MUTYH polymorphisms rs3219463 and rs3219476 between RA patients and controls.
  • Haplotypes Ht6-GTGC and Ht8-GGCG showed reduced prevalence in RA patients compared to controls.
  • The rs3219463 polymorphism was associated with increased frequency in RA patients with immunoglobulin M rheumatoid factors.

Conclusions:

  • The MUTYH gene polymorphisms rs3219463 and rs3219476 are associated with rheumatoid arthritis susceptibility in the studied Taiwanese population.
  • These findings suggest that the MUTYH gene may contribute to the development and progression of RA.
  • Further research is warranted to elucidate the precise mechanisms by which MUTYH influences RA pathogenesis.

Related Concept Videos

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
114
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
69
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
16.7K
Mismatch Repair01:20

Mismatch Repair

Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
7.1K
Mismatch Repair01:36

Mismatch Repair

Overview
45.6K
Translation01:31

Translation

Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Proteins are...
22.5K